Showing 1 posts of 1 posts found.
Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …
Care Quality Commission appoints Emily Miles as Chief Executive
National survey aims to improve glaucoma care across the UK
Phase 3 trials support expanded use of Dysport for migraine prevention
Roche secures CE Mark for automated latent tuberculosis blood test
ReproNovo Phase 2 fertility study doses first participant